Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Sep 20;4(1):25.
doi: 10.1038/s41572-018-0023-6.

Dystonia

Affiliations
Review

Dystonia

Bettina Balint et al. Nat Rev Dis Primers. .

Erratum in

  • Author Correction: Dystonia.
    Balint B, Mencacci NE, Valente EM, Pisani A, Rothwell J, Jankovic J, Vidailhet M, Bhatia KP. Balint B, et al. Nat Rev Dis Primers. 2018 Oct 19;4(1):37. doi: 10.1038/s41572-018-0039-y. Nat Rev Dis Primers. 2018. PMID: 30341354

Abstract

Dystonia is a neurological condition characterized by abnormal involuntary movements or postures owing to sustained or intermittent muscle contractions. Dystonia can be the manifesting neurological sign of many disorders, either in isolation (isolated dystonia) or with additional signs (combined dystonia). The main focus of this Primer is forms of isolated dystonia of idiopathic or genetic aetiology. These disorders differ in manifestations and severity but can affect all age groups and lead to substantial disability and impaired quality of life. The discovery of genes underlying the mendelian forms of isolated or combined dystonia has led to a better understanding of its pathophysiology. In some of the most common genetic dystonias, such as those caused by TOR1A, THAP1, GCH1 and KMT2B mutations, and idiopathic dystonia, these mechanisms include abnormalities in transcriptional regulation, striatal dopaminergic signalling and synaptic plasticity and a loss of inhibition at neuronal circuits. The diagnosis of dystonia is largely based on clinical signs, and the diagnosis and aetiological definition of this disorder remain a challenge. Effective symptomatic treatments with pharmacological therapy (anticholinergics), intramuscular botulinum toxin injection and deep brain stimulation are available; however, future research will hopefully lead to reliable biomarkers, better treatments and cure of this disorder.

PubMed Disclaimer

References

    1. Fahn, S., Bressman, S. B. & Marsden, C. D. Classification of dystonia. Adv. Neurol. 78, 1–10 (1998). - DOI
    1. Albanese, A. et al. Phenomenology and classification of dystonia: a consensus update. Mov. Disord. 28, 863–873 (2013). This is a consensus update that contains the definition of dystonia and its clinical manifestations and the new classification of dystonia. - PMC - PubMed - DOI
    1. Jankovic, J. Treatment of hyperkinetic movement disorders. Lancet Neurol. 8, 844–856 (2009). - DOI
    1. Steeves, T. D., Day, L., Dykeman, J., Jette, N. & Pringsheim, T. The prevalence of primary dystonia: a systematic review and meta-analysis. Mov. Disord. 27, 1789–1796 (2012). This is a systematic review and meta-analysis of the prevalence of isolated dystonia. - DOI
    1. Das, S. K. et al. Community survey of primary dystonia in the city of Kolkata, India. Mov. Disord. 22, 2031–2036 (2007). - DOI

Publication types

MeSH terms

Supplementary concepts